Royal Bank of Canada
ACHL

Royal Bank of Canada’s Achilles Therapeutics ACHL Stock Holding History

Royal Bank of Canada’s Portfolio ACHL Stock Details ACHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed – – 7624
2024
Q2 		$0 Hold
35
– – ﹤0.01% 7657
2024
Q1 		$0 Hold
35
– – ﹤0.01% 7730
2023
Q4 		$0 Hold
35
– – ﹤0.01% 7693
2023
Q3 		$0 Hold
35
– – ﹤0.01% 7717
2023
Q2 		$0 Hold
35
– – ﹤0.01% 7752
2023
Q1 		$0 Hold
35
– – ﹤0.01% 7594
2022
Q4 		$0 Sell
35
-105
-75% -$177 ﹤0.01% 7839
2022
Q3 		$0 Buy
+140
New +$396 ﹤0.01% 7973
2022
Q1 		– Sell
-1,000
Closed -$5K – 8102
2021
Q4 		$5K Hold
1,000
– – ﹤0.01% 7233
2021
Q3 		$8K Hold
1,000
– – ﹤0.01% 7040
2021
Q2 		$10K Buy
+1,000
New +$13.6K ﹤0.01% 6879

Other funds holding ACHL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada's ACHL Position: Q3 2024 in Review

Royal Bank of Canada sold out of Achilles Therapeutics (ACHL) in Q3 2024, closing a stake of 35 shares.

Royal Bank of Canada first reported a position in ACHL in Q2 2021 and held it in 11 quarters. The position peaked at $10K in Q2 2021. 22 funds tracked by Wall St. Rank hold ACHL as of Q3 2024.

  • Royal Bank of Canada reported no remaining Achilles Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 35 Achilles Therapeutics shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Achilles Therapeutics in Q2 2021 and held it in 11 quarters.
  • Royal Bank of Canada's Achilles Therapeutics position peaked at $10K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Achilles Therapeutics as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.